EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Visceral Leishmaniasis in Afghanistan: Analysis of Cases from 2018 to 2022

Khwaja Mir Islam Saeed, Mohammad Shoaib Tamim, Mir Salamuddin Hakim, Shoaib Naeemi, Abdur Rahman Shirindil, Lutfullah Noori, Sayed Hussain Mosawi

Afghanistan Journal of Infectious Diseases · 2024

DOI: 10.60141/ajid.111 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Afghanistan Journal of Infectious Diseases, 2024. Verfasst von Khwaja Mir Islam Saeed und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Visceral leishmaniasis (VL) is a neglected but typically fatal vector-borne protozoan disease. It leads to substantial health problems and/or death for up to 400,000 people per year. Afghanistan is an endemic country for VL. We aimed to analyze VL cases from 2018 to 2022 and enlighten the epidemiological profile of the disease in the country.

Methods

A descriptive analysis of VL cases from 2018 to 2022 was conducted during July to September 2022. Secondary data of the VL surveillance were retrieved from Malaria and other Vector Borne Disease Control Program (MVDP) of Ministry of Public Health, Kabul, Afghanistan. while the outcome of registered cases were confirmed through phone calls. Data were managed and analyzed using MS Excel, Epi Info V.7.2.1, and GIS.

Results

Overall, 77 cases were registered and reported from 2018 to 2022. Most of the cases 48 (62%) were male, and 68 (88.3%) were aged 0-5 yr with a mean of 3.6 ± 2.1. Geographically, 28 cases (36%) were reported from Faryab Province followed by Baghlan 9 (12%) and Ghazni 1 (1.2%) provinces. Only Four (5%) and 7 (9%) cases reported family members with Cutaneous Leishmaniasis and VL respectively. Common clinical manifestations among patients were fever (96%), weight loss (96%), and splenomegaly (91%). Upon follow up, 35 (45.5%) of the cases were lost, 31 (40.2%) were cured, and 11 (14.3%) deceased. The outcome of treatment was significantly associated with treatment type, Glucantime.

Conclusion

We found higher proportion of VL among under-five males. Most of the cases were reported from the northern region and the family history of VL was reported by patients. Fever and weight loss were the frequent clinical manifestations. Early diagnosis and Glucantime had good outcome compared to late diagnosis and SSG. Awareness activities, access to diagnosis, health education and interventions are recommended in high-risk provinces. In addition, further studies are encouraged to determine the prevalence of the disease among the general population.

Zitieren

APA

Saeed, K. M. I., Tamim, M. S., Hakim, M. S., Naeemi, S., Shirindil, A. R., Noori, L., & Mosawi, S. H. (2024). Visceral Leishmaniasis in Afghanistan: Analysis of Cases from 2018 to 2022. Afghanistan Journal of Infectious Diseases. https://doi.org/10.60141/ajid.111

Vancouver

Saeed KMI, Tamim MS, Hakim MS, Naeemi S, Shirindil AR, Noori L, et al. Visceral Leishmaniasis in Afghanistan: Analysis of Cases from 2018 to 2022. Afghanistan Journal of Infectious Diseases. 2024. doi:10.60141/ajid.111

BibTeX
@article{Saeed2024,
  author = {Saeed, Khwaja Mir Islam and Tamim, Mohammad Shoaib and Hakim, Mir Salamuddin and Naeemi, Shoaib and Shirindil, Abdur Rahman and Noori, Lutfullah and Mosawi, Sayed Hussain},
  title = {Visceral Leishmaniasis in Afghanistan: Analysis of Cases from 2018 to 2022},
  journal = {Afghanistan Journal of Infectious Diseases},
  year = {2024},
  doi = {10.60141/ajid.111}
}
Kostenlos starten →